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Abstract
Objectives—The primary aim of this study was to test hypothesized associations between
changes in psychological variables (i.e., pain beliefs, catastrophizing and coping strategies) and
changes in pain intensity and related adjustment (i.e., pain interference and psychological
functioning) in individuals with Myotonic Muscular Dystrophy (MMD) and Facioscapulohumeral
Muscular Dystrophy (FSHD).
Methods—A sample of 107 adults with a diagnosis of MMD or FSHD, reporting pain in the past
three months, completed assessments at two time-points, separated by about 24 months.
Results—Results showed that changes in pain-related psychological variables were significantly
associated with changes in psychological functioning, pain intensity and pain interference.
Specifically, increases in the belief that emotion influences pain, and catastrophizing were
associated with decreases in psychological functioning. Increases in the coping strategies of asking
for assistance and resting, and the increases of catastrophizing were associated with increases in
pain intensity. Finally, increases in pain intensity and asking for assistance were associated with
increases in pain interference.
Discussion—The results support the utility of the biopsychosocial model of pain for
understanding pain and its impact in individuals with MMD or FSHD. These findings may inform
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the design and implementation of psychosocial pain treatments for people with muscular
dystrophy and chronic pain.
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INTRODUCTION
Myotonic Muscular Dystrophy (MMD) and Facioscapulohumeral Muscular Dystrophy
(FSHD) are two common subtypes of muscular dystrophy1. Pain is a widespread problem in
persons with both types of muscular dystrophy2,3. For example, a recent study by Jensen et
al. 4 reported that 71% of a sample of patients with MMD or FSHD had experienced
bothersome pain in the last three months. The average pain intensity in their sample was in
the moderate range (4.45 on a 0-10 numerical rating scale; NRS), while 25% of participants
with pain experienced severe pain intensity (rated 7 or higher on a 0-10 NRS). Patients also
reported that pain significantly interfered with their daily activities, primarily with
recreational activities and mobility.
Although pain in these populations is likely related to underlying physiological processes,
there is consistent evidence indicating that psychological and social factors also play an
important role in the experience and impact of pain5,6. Specifically, biopsychosocial models
propose that pain is best viewed as the product of a complex interaction of physical,
cognitive, emotional, behavioral, and social factors7 that, together, influence the experience
of pain and psychological well-being. This model is supported by prior research on
numerous patient populations with pain secondary to physical disability, including spinal
cord injury8-10, amputation11,12 , cerebral palsy13, and, more recently, neuromuscular
disease14. The model has also provided an important theoretical basis for the design of
multidisciplinary pain treatments that seek to address the interplay and effectiveness of these
aforementioned factors15-19.
In a recent study, specific to neuromuscular disease, Miró et al.14 analyzed three
biopsychosocial domains, including pain beliefs, pain-related catastrophizing, and perceived
social support in a sample of persons diagnosed with MMD or FSHD. The results of this
study were consistent with the tenets of the biopsychosocial model of pain, and showed that
34% of the variance in psychological functioning in the sample was explained by patients’
pain beliefs, catastrophic thinking and perceived social support, above and beyond that
explained by pain intensity alone. Moreover, patients’ pain beliefs, catastrophic thinking,
coping strategies and perceived social support explained 19% of the variance in interference
of pain in their daily activities, also above pain intensity.
The findings of this study add to a broader literature supporting the use of a biopsychosocial
framework to better understand pain and functioning in persons with degenerative and acute
illnesses, as well as those diagnosed by MMD or FSHD. However, a common limitation of
the current research is that results are often based on cross-sectional analyses, thus limiting
our ability to ascertain whether psychological and social factors are the consequence of
functioning or, likewise, if such psychosocial factors directly impact pain-related
functioning. In order to better understand the possible direction of these relationships,
studies are needed that move beyond the analysis of cross-sectional data, and implement
longitudinal designs to investigate whether changes in the predictive factors are also
associated with changes in the outcomes.
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The purpose of the current study is to investigate the relationship between changes in pain-
related psychological variables (i.e., pain beliefs, catastrophizing and pain coping strategies)
and changes in pain intensity and related adjustment (i.e., pain interference and
psychological functioning) in a sample of individuals with muscular dystrophy (in this case,
samples of individuals with MMD or FSHD). We hypothesized that changes in pain-related
psychological variables would be significantly associated with changes in pain adjustment;
specifically that changes in catastrophizing as well as pain beliefs and coping strategies
deemed maladaptive would be associated negatively with psychological functioning and
positively with pain intensity and pain interference over time, and that pain beliefs and
coping strategies deemed adaptive would show the opposite pattern to measures of pain and
patient functioning.
MATERIALS AND METHODS
Participants
The participants in the current study consisted of adults with a primary diagnosis of
neuromuscular disease (NMD) completing assessments at two time-points (termed initial
and 24-month). Participants were recruited from the NIH-funded National Registry of
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family
Members (http://www.urmc.rochester.edu/nihregistry/), and from the University of
Washington NMD Clinic. To be eligible to participate in this study, participants must have
had a diagnosis of either FSHD or MMD, be at least 18 years old, be able to read and write
English, and report pain in the past 3 months (other than occasional headaches and
menstrual cramps).
A total of 395 questionnaires were mailed to potential participants for the initial survey. Of
these, 97 were not returned (2 because the participant no longer lived at the address on
record, 6 were deceased, 5 were returned as ineligible -no MMD diagnosis or less than 18
years of age-, and 84 were not returned for unknown reasons). Thus, a total of 298 surveys
were completed and returned, although data from 5 of these could not be analyzed and were,
therefore, excluded from further analysis. One hundred eleven of the respondents were not
eligible to participate in this study (75 did not report pain and 36 did not have diagnosis of
NMD or FSHD). The final sample consisted of 182 individuals, and the data from these
participants was used in the analyses of the initial survey (see Miró et al.14 for more details
of the participating sample).
Two years following the initial survey, a second one was mailed to those individuals who
had completed the initial survey and reported pain (n = 182). One hundred and seven
participants completed and returned the 24-month survey (58.8% of the 182 persons that
participated in the initial assessment). There were no significant differences in age, pain
severity at the initial survey, sex, or education level (all ps > .05) between participants who
did and those who did not completed both initial and follow-up surveys. The University of
Washington Human Subjects Review Committee approved all study procedures. All
participants provided informed consent.
Among the 107 respondents with pain included in the current analyses, 61 were female
(57.0%) with a mean age of 50.22 years (SD = 12.30, range = 20 - 83). The majority of the
participants were Caucasian (96.3%), married (70.1%), and unemployed (85.9%). All
participants had at least a high school education or had obtained their general educational
development (GED). Of the 107 respondents, 65.4% were diagnosed with FSHD and 34.6%
with MMD. The participants averaged 16.48 years (SD=12.16, range= 10 months-49 years)
since their initial MMD diagnosis. Only 6.5% of the participants had no mobility limitations.
Likewise, 48.6% were using some form of assistance for ambulatory circulation.
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Measures
Outcome Variables—Pain inference was measured using the Brief Pain Inventory
(BPI) 20,21, which includes 7-items asking respondents to indicate the extent to which pain
interferes with certain activities (general activity, mood, walking ability, normal work,
relations with other people, sleep, and enjoyment of life). For the purposes of assessing pain
interference in the current study population, we modified the original scale to: (1) expand
the interference domains assessed to three additional activity areas (self-care, recreational
activities, and social activities) and (2) ask about interference with mobility instead of ability
to walk, because there are individuals with MD who are unable to walk because of their
disability (see the following for more details regarding the modified BPI Interference
scale: 11, 14, 22). The modified BPI Interference scale score (see Table 1) can range from 0 to
10 with a higher score indicating a higher degree of pain-related interference. Our modified
10-item version has evidenced excellent internal consistency (Cronbach’s alpha=.89-.95)
and validity in previous research examining secondary pain in persons with cerebral palsy23,
limb loss11, and persons with SCI24.
Psychological Functioning: The 5-item SF-36 Mental Health scale from the SF-36 was
used to assess psychological functioning 25. The SF-36 Mental Health scale is a widely used
measure of psychological functioning and has demonstrated good reliability, as evidenced
by high internal consistency coefficients (0.81 – 0.95) and test re-test stability coefficients
(0.75 – 0.80)25. It has also demonstrated validity as a measure of psychological functioning
by its association with other measures of psychological functioning26. Scores on the SF-36
Mental Health scale range from 0 to 100, with higher scores indicating better psychological
functioning. The same 5-item SF-36 Mental Health scale from the SF-36 was administered
both at the initial and 24-month surveys (See Table 1).
Pain Intensity: Participants were asked, at the time of the initial survey, the following
question regarding current pain: “Are you currently experiencing, or have you in the past
three months experienced any pain (other than occasional headaches or menstrual cramps)?”
Participants who reported pain (those included in this study) were then asked to rate the
intensity of their average overall pain in the past week on a 0-10 Numerical Rating Scale,
with “0” indicating “no pain” and a “10” indicating “pain as bad as it could be.” This same
scale was used at the 24-month survey. Numerical rating scales evidence a strong
association with other measures of pain intensity and stability over time thus demonstrating
their validity and reliability as measures of pain27. The mean and standard deviations of the
0-10 NRS pain intensity measure at each time point, as well as average change scores from
the initial to 24-month surveys, are presented in Table 1.
Process Variables
Pain Cognitions: For the initial survey, the standard 57-item Survey of Pain Attitudes was
used (SOPA)28, while the shorter, 14-item, version of the SOPA was administered at the
time of the 24-month survey29. Both versions of the SOPA include 7 subscales that measure
seven pain-related beliefs, including Control, Disability, Harm, Emotion, Medication,
Solicitude, and Medical Cure. The 57-item SOPA has evidenced good internal consistency
(Cronbach’s alpha=.71-.81), test-retest reliability, and validity28,30. The shorter version of
the SOPA has also demonstrated excellent validity through its relationship with parent
scales, as well as strong correlations with measures of depression, disability, and pain
intensity29. In order to calculate change scores in the SOPA between the two time periods,
only the overlapping items between the two scales were used (see Table 1).
Pain-Related Catastrophizing: Pain-Related Catastrophizing was assessed at the initial
survey with the 6-item Catastrophizing subscale of the Coping Strategies Questionnaire
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(CSQ) 31, that has evidenced excellent internal consistency reliability32-36 and adequate
validity 12,22,37-40. For the 24-month survey, the Pain Catastrophizing Scale (PCS)41 was
used. This scale includes 13 statements on catastrophic thinking about pain, and has shown
adequate psychometric properties in non-clinical populations42,43 and in different clinical
populations ,44-47. In the initial survey, the 6-item CSQ catastrophizing scale was used to
minimize assessment burden, as many questionnaires were administered for that survey.
However, the number of measures was fewer in the second survey, which allowed us to
administer the longer measure of catastrophizing that is now used in most of the studies on
catastrophizing (the PCS).
In order to standardize these measures across the two assessment points, thus rendering them
useful for calculating change scores, we computed scores based only on the five overlapping
items between the two measures. In order to ensure that the 5 overlapping items had
adequate psychometric properties, and are therefore adequate for assessing catastrophizing,
we examined the internal reliability and validity of these items from each assessment.
Internal consistency was excellent in both assessments (Chronbach’s alpha = .90 for the
initial assessment, and .87 for the 24-month assessment) and were strongly correlated with
one another (r = .54, p < .001), supporting both their reliability and validity as measures of
catastrophizing. Finally, we standardized the scales for comparison, as they were each
measured on different Likert scales, using the strategy implemented for the SF-3625. With
this procedure both measurements were converted to the same 0 to 100 scale (see Table 1).
Coping: The standard 70-item Chronic Pain Coping Inventory (CPCI) 48 was administered
at the time of the initial survey, while a shorter 12-item version of the CPCI 29 (this included
a one-item version of each scale, except for Pacing, which, in the version administered for
this study, included all original 5 items, as a brief version of the CPCI Pacing scale has not
yet been developed) was included in the 24-month survey. Both the standard and brief
versions of the CPCI assess the frequency with which participants use nine coping strategies
for pain management, including Guarding, Resting, Asking for Assistance, Relaxation, Task
Persistence, Seeking Social Support, Coping Self-Statements, Exercise/Stretch and Pacing.
However, the Exercise/Stretch scale items were not included in the 24-month survey due to
an oversight. The validity of the 70-item CPCI is demonstrated by strong correlations
between patient and significant other versions of the scales, as well as with measures of
depression and adjustment to pain49,50. The shorter 12-item version of the CPCI has also
demonstrated robust validity, evidenced by strong correlations between the two-item
subscales and parent scales, as well as correlations with measures of depression, disability,
and pain intensity29.
For the purposes of this paper we only examined the overlapping CPCI items administered
at each assessment point. Specifically, we examined the single items that overlapped and
assessed Guarding, Resting, Asking for Assistance, Relaxation, Task Persistence, Seeking
Social Support, and Coping Self-Statements. Because all 5 original items for the Pacing
Scale were available in both surveys, we utilized the mean score for these five items from
both time-points (see Table 1).
Data Analyses
We first performed a series of analyses (zero-order correlations, independent samples t-tests,
and ANOVAs) to examine the extent to which demographic characteristics (i.e., age and
education) and change in pain intensity (e.g., pain intensity in previous week the time of the
24-month survey minus pain intensity at the time of the initial survey) were related with the
outcome variables of interest, including change in psychological functioning, change in pain
interference, and change in pain intensity, in order to determine which variables might be
needed as control variables in the planned multivariate analyses. Change in average pain
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intensity from the initial to the 24-month assessment was significantly positively correlated
with change in psychological functioning (r = .22, p < .05) and change in pain interference (r
= .42, p < .01). Thus, change in pain intensity was entered first in subsequent regression
analyses to control for this variable. No other potential control variables were significantly
related to any of the outcome variables.
We then subjected the CPCI and SOPA subscale change scores to principal components
analyses (PCA) in order to reduce the number of predictor variables in the planned
regression equations. Direct Oblimin was chosen to allow correlations between different
components. We used the scree plot test, Kaiser criterion, amount of variance explained, and
the coherence of the structure to determine the number of factors for each component
analysis.
The results of the PCA of the CPCI subscales showed a clear two-factor structure which
accounted for 40.49% of the variance. Four scale scores loaded on the first component,
including Task Persistence (component loading = .63), Asking for Assistance (.53), Seeking
Social Support (.72), and Relaxation (.54). Three scale scores loaded on the second
component, including Coping Self-Statements (.59), Guarding (r = .55) and Resting (.69).
Pacing was partially loaded onto both component 1 (.41) and component 2 (.36).
The results of the PCA of the SOPA showed a three-factor structure that accounted for
59.38% of the variance. The subscale scores that loaded on the first component included
Control (component loading = −.80), and Harm (.79) scale scores. The second component
included the Disability (.76), and Emotion (.73) scales. The third component included only
the Solicitude (.72) scale. Medication Cure loaded on both component 2 (.49) and
component 3 (.56). Likewise, Medical Cure loaded equally on component 1 (−.53) and
component 3 (.53).
To test the study hypotheses, we performed a series of three regression analyses, including
component scores from the factor analyses of the SOPA and CPCI scales, and scores from
the catastrophizing scale (representing pain cognitions and coping), as the primary
predictors. Change in pain intensity was entered in the first step of the regression analyses
predicting change in pain interference and change in psychological functioning, to control
for its effect on these criterion measures. To help better understand the specific factors that
contributed to the significant effects found in the regression analyses, we also examined the
univariate relationships between specific psychosocial variables, including change scores of
each subscale of the CPCI , SOPA and catastrophizing scales, and the outcome variables of
interest (change in pain interference, pain intensity, and psychological functioning) using
correlation analyses.
Due to the large number of predictive variables and statistical tests performed, we used an
alpha of .01 to balance the needs to control for both Type I, as well as Type II, errors26.
RESULTS
Associations Between Psychosocial Variables and Change in Psychological Functioning
Change in pain intensity demonstrated a non-significant trend (p < .05) to be associated with
change in psychological functioning, explaining 5% of the variance. After controlling for
change in pain intensity, cognitions and coping strategies as a whole also demonstrated a
non-significant trend (p<.05) to be associated with change in psychological functioning, and
accounted for an additional 12% of the variance. However, none of the pain cognitions and
coping variables uniquely predicted psychological functioning (see Table 2).
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In the univariate analyses, no CPCI subscale emerged as significantly associated with
psychological functioning. However, changes in the SOPA Emotion subscale (r = .27, p < .
01) were associated with changes in psychological functioning; larger initial to 24-month
increases in this subscale were associated with worsening of psychological functioning.
Catastrophizing change scores were also positively associated with changes in psychological
functioning (r = .25, p < .01). Finally, there was a non-significant trend between increases in
pain intensity and worsening of psychological functioning (r = .22, p < .05; see Table 3).
Associations Between Psychosocial Variables and Change in Pain Interference
Initial to 24-month changes in pain intensity showed a positive non-significant trend (p < .
05) to be associated with changes in pain interference, explaining 18% of the variance in this
criterion. Changes in the cognition and coping variables as a whole accounted for an
additional 6% of the variance in changes in pain interference scores, after controlling for
change in pain intensity, but as a block did not evidence a significant contribution to the
variance of the outcome. However, the SOPA component 2 made a significant and unique
contribution to the prediction of the criterion, with more change in this component
associated with more change in pain interference (p < .01) (See Table 4).
The univariate analyses indicated that Asking for Assistance was significantly and positively
associated with change in pain interference (r = .33, p < .01). Change scores of the SOPA
Medication subscale, as well as the change in Catastrophizing, also evidenced a non-
significant positive trend with change in pain interference (each r = .19, ps = .05). Finally,
increased pain intensity over time was strongly associated with an increase in pain
interference over time (r = .42, p < .01) (see Table 4).
Associations Between Psychosocial Variables and Change in Pain Intensity
In the regression analysis predicting change in pain intensity, the cognitions and coping
variables as a whole showed a non-significant trend (p < .05) to be associated with the
criterion, accounting for 16% of the variance. Change in Catastrophizing made a unique and
significant contribution to the prediction of the criterion (p<.01), such that increases in
Catastrophizing (p < .01) were associated with increases in pain intensity (See Table 5).
There was also a non-significant positive trend towards the relation between CPCI
Component 1 and pain intensity (p<0.05).
The results of the univariate analyses indicated that change in the CPCI Resting (r = .29, p
< .01) and Asking for Assistance (r = .28, p < .01) subscales were significantly and
positively correlated with change in pain intensity. Finally, consistent with the multivariate
analyses, change in Catastrophizing was positively and significantly associated with change
in pain intensity (r = .29, p < .01) (see Table 3).
DISCUSSION
In general, the most important contribution of this longitudinal study is the finding that, as
hypothesized, changes in psychosocial factors predicted changes in the experience of, and
adjustment to, pain in persons with MMD or FSHD, thus providing support for a
biopsychosocial model to understand pain and its impact in this patient population. These
results add to a growing literature supporting the use of a biopsychosocial model to better
understand pain in numerous patient populations, as well as the potential efficacy of
psychosocial pain treatments to help individuals with MD and chronic pain. More
specifically, our multivariate analyses revealed that changes in catastrophizing significantly
predicted changes in pain intensity, and that changes in SOPA component 2 significantly
predicted changes in pain interference after controlling for changes in pain intensity.
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However, in the regression analyses, no block or individual predictor was significantly
associated with psychological functioning.
Taken together, these findings are in accordance with our previous cross-sectional study14 in
which concurrent scores in psychological variables (i.e., beliefs, catastrophizing and coping)
and social support were significantly related with concurrent pain interference. Similar
results have been found in the recent study by Hanley et al.8 that also assessed the effects of
changes of psychological variables in a sample of persons with pain secondary to cerebral
palsy, as well as other populations with disabilities and chronic pain, including spinal cord
injury9,10, and amputation11,12.
While the primary goal of the current longitudinal study was to further establish the
importance of a biopsychosocial model, we also examined the univariate relationships
between specific psychosocial variables (including change scores of each subscale of the
CPCI and SOPA, and catastrophizing), and the outcome variables of interest. Concerning
coping strategies (as measured by subscales of the CPCI), increases in “asking for
assistance” was associated with increases in pain intensity and pain interference over time;
and increases in the use of “resting” was related with increases in pain intensity. Because
these findings are correlational, it is not possible to conclude that the coping responses of
“asking for assistance” and “resting” contribute to increases in pain, if increases in pain
contribute to a greater frequency of use of these coping strategies, or if there is a third
variable or confound that influences both and is responsible for the significant associations
found. However, because correlation is a necessary (but not sufficient) criterion for
causality, the findings are consistent with the possibility that use of these coping responses
might contribute to greater pain over time; for example, via a mechanism by which greater
reliance on others (asking for help with a chore or task) and increased resting in response to
pain contribute to decreased activity and deconditioning. Future research is needed to
determine if experimental manipulation of these coping strategies (e.g., random assignment
to conditions that (a) have little impact on rest vs. (b) decrease the use of rest as a coping
response) have a causal impact on pain intensity over time. Certainly, however, these results
are consistent with our previous cross-sectional study14 and previous literature showing the
potential importance of coping strategies in chronic pain51, especially the negative
associations between both resting and asking for assistance and pain intensity9,52-54.
Concerning beliefs and cognitions (as measured by the SOPA), univariate analyses showed
that increases in the belief that emotions influence pain was related with decreases in
psychological functioning over time. However, this result should be interpreted with
caution, because none of the predictors in the multivariate regression analysis evidenced a
significant (p < .01) association with changes in psychological functioning. Also, even if this
finding were reliable, it is not possible to determine the direction of causation from these
analyses. To the extent that future research shows that beliefs in the effects of emotions on
pain make one more vulnerable to psychological distress this would support the need to
develop treatments that target these beliefs, specifically.
The univariate results also revealed that catastrophizing was one of the variables most
widely related with the outcomes assessed in our study, consistent with a large body of
research supporting the importance of catastrophizing in many other samples of chronic pain
conditions, including samples of individuals with physical disabilities 9-13,22, 55,,56.
Increases in catastrophic thinking were related with worsening pain intensity in both the
univariate and multivariate analyses, and with mental health in the univariate analyses.
Besides the limitations associated with correlational analyses previously discussed, this
finding adds to the growing literature regarding the importance of catastrophizing in the
context of numerous pain populations 6,57,58, and are also consistent with our previous
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cross-sectional study of the same sample14. Altogether, these data suggest the central role
that catastrophic thinking may exert in the experience and impact of pain and calls for
additional research to examine more closely the causal direction of this relationship.
As mentioned earlier, the findings from this study may inform relevant therapeutic
alternatives for patients with MMD and FSHD diseases. Treatments should be developed on
the basic tenets of the biopsychosocial model, including cognitive and behavioural
interventions aimed at changing maladaptative thoughts, such as catastrophizing, and
teaching as well as encouraging the use of more adaptative coping strategies. A substantial
amount of evidence supports the use of these treatments for other chronic pain
populations15-19. Moreover, several studies have also shown that treatment-related changes
in coping strategies and cognitions are related with improvements in pain adjustment26,59.
Cognitive-behavioral approaches for pain treatment should be tested in persons with NMD
and FSHD in order to evaluate its effectiveness and further unravel the direction and
importance of the aforementioned variables identified as important correlates of changes to
the outcomes in the current study.
Several limitations of this study should be noted. First, the sample size was relatively small
and there was no follow-up data for almost half of the sample, thus bringing into question
the external validity of our findings. Moreover, we cannot be sure that our sample is
representative of the population of persons with FSHD and/or MMD. Research testing the
associations between variables examined in this study in additional samples of individuals
with FSHD and NMD is needed to establish their reliability. Second, at the 24-month
follow-up we used brief measures for coping strategies and beliefs in order to reduce
assessment burden. Although these measures have shown adequate psychometric
properties29, this presented unique challenges in the process of standardizing the measures at
both time-points and possible differences in the psychometric properties of these measures
between assessment periods may have influenced the results in ways that are not easily
assessed. Third, although we used a longitudinal design, which is somewhat more reliable
for testing causal relationships than cross-sectional designs, it must be acknowledged that
results are still correlational. Therefore, we cannot determine the direction of causality in the
associations found. Studies using experimental methodology are needed to truly examine the
potential causal relationships. Also, we did not measure a number of psychological and
social variables that have been supported as significant predictors of patient functioning in
previous studies. One of these, related with pain adjustment in our previous study14, is social
support, which has evidenced an important relationship with similar outcomes in other
studies, as well 10-12. Finally, we did not assess a number of important disease-related
variables (for example, disease severity or progression), which would have allowed us to
determine how these variables are associated with the criterion variables studied, as well as
the extent to which the psychosocial variables examined contributed to the prediction of the
criterion variables over and above disease-related factors. Future researchers should assess
these variables in order to help build a more thorough biopsychosocial understanding of the
factors that may contribute to pain, psychological functioning, and disability.
In sum, the current study contributes to the increasing evidence that the biopsychosocial
model provides a useful framework for understanding pain and pain adjustment in
populations of individuals with physical disabilities, including persons with MMD and
FSHD. The findings also suggest that interdisciplinary pain treatments that have proven
efficacy in other samples of patients with pain should be tested in samples of patients with
muscular dystrophy and chronic pain, and that such treatments should continue to focus on a
broad range of biopsychosocial factors (e.g., cognitions and beliefs, coping responses) as
each one of these has the potential to exert a role in the experience of pain and its impact on
quality of life.
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Table1
Descriptive Statistics of Study Measures
Measures Initial SurveyMean (SD)
24-Month Survey
Mean (SD)
Change Scores
(24-Month -
Initial scores)
Mean (SD)
Range of
change scores
0 – 10 NRS 4.74 (2.39) 4.85 (2.31) .11 (2.30) −6.00 – 8.00
BPI Interference scale 3.14 (2.40) 3.23 (2.23) .09 (2.07) −6.33 – 6.17
SF-36 MHS 31.36 (18.39) 32.88 (19.81) 1.56 (16.37) −57.00 – 63.00
Catastrophizing (CSQ, PCS) 21.56 (20.13) 18.92 (22.12) −2.63 (20.54) −66.67 – 76.67
SOPA
Control 1.87 (.77) 2.26 (.95) .38 (1.13) −2.50 – 4.00
Disability 2.00 (1.11) 1.93 (1.14) −.08 (1.85) −4.00 – 4.00
Harm 1.83 (.94) 2.20 (.98) .37 (1.39) −3.00 – 4.00
Emotion 1.70 (1.14) 1.88 (1.22) .17 (1.29) −3.00 – 3.50
Solicitude 1.74 (1.10) 1.88 (1.14) .14 (.99) −3.00 – 2.50
Medication 1.53 (.78) 2.81 (1.02) 1.30 (1.14) −2.00 – 4.00
Medical Cure 2.04 (.79) 1.28 (1.05) −.75 (1.30) −4.00 – 3.00
CPCI
Guarding 4.72 (2.76) 4.65 (2.72) −.20 (2.98) −7.00 – 7.00
Resting 3.87 (3.04) 2.70 (2.72) −1.17 (3.22) −7.00 – 7.00
Asking for Assistance 3.62 (2.58) 3.08 (2.43) −.53 (2.57) −7.00 – 7.00
Relaxation 1.97 (2.42) 2.38 (2.64) .41 (3.12) −7.00 – 7.00
Task Persistence 4.09 (2.60) 3.69 (2.60) −.40 (3.03) −7.00 – 7.00
Coping Self-Statements 2.00 (2.56) 2.20 (2.54) .20 (2.88) −7.00 – 7.00
Seek Social Support 1.15 (2.01) 2.08 (2.59) .93 (2.93) −7.00 – 7.00
Pacing 3.60 (2.02) 4.16 (2.05) .56 (2.20) −4.40 – 7.00
Note: 0 – 10 NRS = 0 to 10 Numerical Rating Scale of pain intensity; BPI = Modified Brief Pain Inventory Pain Interference scale; SF-36 MHS =
Mental Health Scale; SOPA = Survey of Pain Attitudes; CSQ = Coping Strategies Questionnaire; CPCI = Chronic Pain Coping Inventory; PCS =
Sullivan’s Pain Catastrophizing Scale.
Note: 0 – 10 NRS = 0 to 10 Numerical Rating Scale of pain intensity; BPI = Modified Brief Pain Inventory Pain Interference scale; SF-36 MHS =
Mental Health Scale; SOPA = Survey of Pain Attitudes; CSQ = Coping Strategies Questionnaire; CPCI = Chronic Pain Coping Inventory; MSPSS
= Multi-Dimensional Scale of Perceived Social Support.
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Table 2
Multiple Regression Analyses Predicting Change in Psychological functioning from Change in Cognitions &
Coping (n = 101) Δ
Step and Variables Total R2 R2 change F change Beta
1. Pain intensity .05 .05 5.67* .23*
2. Cognitions and Coping .17 .12 2.25*
Catastrophizing .18
SOPA Component 1 .10
SOPA Component 2 .17
SOPA Component 3 .15
CPCI Component 1 −.19
CPCI Component 2 .03
*
p<.05,
**
p< 0.01,
Δ
Total n < 107 due to missing data
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Table 3
Zero-Order Correlation Coefficients between Subscale Change Scores of the Psychosocial Variables with
Change Scores of Psychological functioning, Brief Pain Inventory and Pain Intensity Scores (24-month -
Initial)
Outcome Measures (Change Scores)
Cognition/coping
change scores
BPI
Interference Scale
SF-36
Mental Health
Pain
Intensity
CPCI subscales
Guarding .00 −.03 .06
Resting −.01 −.01 .29*
Asking for Assistance .33* −.04 .28*
Relaxation .03 −.04 .13
Coping Self-Statements −.20 .04 −.15
Seek Social Support .02 −.04 .09
Task Persistence −.10 −.08 .04
Pacing −.07 .04 −.07
SOPA subscales
Disability .15 .14 .02
Harm −.02 .04 −.01
Medication .19† .04 .08
Medical Cure −.06 −.01 −.09
Emotion .16 .27* .01
Solicitude −.06 .15 .06
Control −.19 −.11 −.11
Catastrophizing .19† .25* .29*
Pain Intensity .42* .22† NA
†
non-significant trend,
*
p < 0.01, two-tailed.
Note. These correlations and significant levels are presented for descriptive purposes. Given the large number of correlations performed on related
variables we used an alpha cut-off of .01 to control for both Type I and Type II error. SOPA = Survey of Pain Attitudes; CPCI = Chronic Pain
Coping Inventory
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Table 4
Multiple Regression Analyses Predicting Change in Pain Interference from Change in Cognitions & Coping
(n=102)Δ
Step and Variables Total R2 R2 change F change Beta
1. Pain Intensity .18 .18 21.16* .42*
2. Cognitions and Coping .24 .06 1.23
Catastrophizing .05
SOPA Component 1 .05
SOPA Component 2 .21**
SOPA Component 3 −.03
CPCI Component 1 −.06
CPCI Component 2 −.07
*
p<.05,
**
p< 0.01,
Δ
Total n < 107 due to missing data.
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Table 5
Multiple Regression Analyses Predicting Change in Pain Intensity from Change in Cognitions & Coping
(n=102)Δ
Step and Variables Total R2 F change Beta
Cognitions and Coping .16 2.92*
Catastrophizing .31**
SOPA Component 1 .03
SOPA Component 2 −.02
SOPA Component 3 −.01
CPCI Component 1 .23*
CPCI Component 2 .06
*
p<.05,
**
p< 0.01,
Δ
Total n < 107 due to missing data
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